Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma-Reference-Cited by-同舟云学术

Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma

Published:2021-05-28 Issue:2 Volume:107 Page:275-282
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Jonsdottir Gudbjorg¹²^ORCID,Björkholm Magnus³,Turesson Ingemar⁴^ORCID,Hultcrantz Malin³⁵,Diamond Benjamin⁵,Porwit Anna⁶,Landgren Ola⁷,Kristinsson Sigurdur Y.¹³^ORCID

Affiliation:

1. Faculty of Medicine University of Iceland Reykjavik Iceland

2. Department of Hematology, Oncology, Blood and Marrow Transplantation University of Iowa Hospitals and Clinics Iowa City IA USA

3. Department of Medicine Division of Hematology Karolinska University Hospital and Karolinska Institutet Stockholm Sweden

4. Department of Hematology Skåne University Hospital Malmö Sweden

5. Myeloma Service Memorial Sloan‐Kettering Center New York NY USA

6. Division of Pathology Department of Clinical Sciences Lund University Lund Sweden

7. Myeloma Program Sylvester Comprehensive Cancer Center University of Miami Miami FL USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13650

Reference61 articles.

1. Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States

2. Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

3. Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry

4. PerrotA Lauwers‐CancesV CazaubielT et al.Early versus late autologous stem cell transplant in newly diagnosed multiple myeloma: long‐term follow‐up analysis of the IFM 2009 trial. 62nd ASH Annual Meeting and Exposition2020.

5. Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma;American Journal of Hematology;2024-08-07

2. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients;Cancers;2023-09-01

3. Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?;Cancers;2023-07-03

4. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

5. Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis;Blood Advances;2023-06-15